Hesslein Robert W.
Senior VP & General Counsel at VYGR; SVP and General Counsel at Foundation Medicine, Inc.
- Sold, on record
- $3.7M
- Dollars the filings state
- Form 4 sales
- 28
- Latest Mar 20, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- VYGRVoyager Therapeutics, Inc.Senior VP & General Counsel
- Foundation Medicine, Inc.SVP and General Counsel
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Foundation Medicine, Inc.75,364 shares
- VYGR34,133 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale VYGRPlan not statedFeb 11, 2022 2022
Sold 3,252 shares at $3.36 ($11k)
Hesslein Robert W., Senior VP & General Counsel
Sold 2.5% of holdings ($437k position)126,804 shares leftFiling
- 2 Form 4 sale VYGRPlan not statedFeb 17, 2022 +6 days
Sold 4,100 shares at $3.55 ($15k)
Hesslein Robert W., Senior VP & General Counsel
Sold 3.2% of holdings ($450k position)122,704 shares left1.3x usual sizeFiling
- 3 Form 4 sale VYGRPlan not statedMar 21, 2022 +32 days
Sold 4,955 shares at $8.29 ($41k)
Hesslein Robert W., Senior VP & General Counsel
Sold 4% of holdings ($1M position)117,749 shares left1.5x usual sizeFiling
- 4 Form 4 sale VYGRPlan not statedApr 4, 2022 +14 days
Sold 2,786 shares at $8.25 ($23k)
Hesslein Robert W., Senior VP & General Counsel
Sold 2.4% of holdings ($971k position)114,963 shares left0.8x usual sizeFiling
- 5 Form 4 sale VYGRPlan not statedJan 17, 2023 +288 days
Sold 2,188 shares at $9.85 ($22k)
Hesslein Robert W., Senior VP & General Counsel
Sold 1.9% of holdings ($1.1M position)112,775 shares left0.7x usual sizeFiling
- 6 Form 4 sale VYGRPlan not statedFeb 13, 2023 +27 days
Sold 2,868 shares at $7.67 ($22k)
Hesslein Robert W., Senior VP & General Counsel
Sold 2.5% of holdings ($865k position)109,907 shares left0.9x usual sizeFiling
- 7 Form 4 sale VYGRPlan not statedFeb 17, 2023 +4 days
Sold 3,297 shares at $7.45 ($25k)
Hesslein Robert W., Senior VP & General Counsel
Sold 3% of holdings ($819k position)106,610 shares left1.1x usual sizeFiling
- 8 Form 4 sale VYGRNo planMar 20, 2023 +31 days
Sold 4,410 shares at $7.76 ($34k)
Hesslein Robert W., Senior VP & General Counsel
No 10b5-1 planSold 4.1% of holdings ($827k position)102,200 shares left1.4x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (28)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 20, 2023 | Mar 22, 2023 | VYGR | Senior VP & General Counsel | Form 4 sale | 4,410 | $34k | 4.1% | No plan | SEC |
| Feb 17, 2023 | Feb 22, 2023 | VYGR | Senior VP & General Counsel | Form 4 sale | 3,297 | $25k | 3.0% | Plan not stated | SEC |
| Feb 13, 2023 | Feb 15, 2023 | VYGR | Senior VP & General Counsel | Form 4 sale | 2,868 | $22k | 2.5% | Plan not stated | SEC |
| Jan 17, 2023 | Jan 19, 2023 | VYGR | Senior VP & General Counsel | Form 4 sale | 2,188 | $22k | 1.9% | Plan not stated | SEC |
| Apr 4, 2022 | Apr 6, 2022 | VYGR | Senior VP & General Counsel | Form 4 sale | 2,786 | $23k | 2.4% | Plan not stated | SEC |
| Mar 21, 2022 | Mar 23, 2022 | VYGR | Senior VP & General Counsel | Form 4 sale | 4,955 | $41k | 4.0% | Plan not stated | SEC |
| Feb 17, 2022 | Feb 22, 2022 | VYGR | Senior VP & General Counsel | Form 4 sale | 4,100 | $15k | 3.2% | Plan not stated | SEC |
| Feb 11, 2022 | Feb 15, 2022 | VYGR | Senior VP & General Counsel | Form 4 sale | 3,252 | $11k | 2.5% | Plan not stated | SEC |
| Feb 11, 2021 | Feb 16, 2021 | VYGR | Senior VP & General Counsel | Form 4 sale | 3,186 | $24k | 6.1% | Plan not stated | SEC |
| Apr 3, 2020 | Apr 7, 2020 | VYGR | Senior VP & General Counsel | Form 4 sale | 3,091 | $26k | 5.6% | Plan not stated | SEC |
| Jul 2, 2018 | Jul 5, 2018 | Foundation Medicine, Inc. | SVP and General Counsel | Form 4 sale | 2,520 | $344k | 2.3% | Plan not stated | SEC |
| Apr 2, 2018 | Apr 3, 2018 | Foundation Medicine, Inc. | SVP and General Counsel | Form 4 sale | 1,585 | $119k | 1.5% | Plan not stated | SEC |
| Jan 16, 2018 | Jan 18, 2018 | Foundation Medicine, Inc. | SVP and General Counsel | Form 4 sale | 18,021 | $1.2M | 15.5% | Unusual | SEC |
| Jan 2, 2018 | Jan 3, 2018 | Foundation Medicine, Inc. | SVP and General Counsel | Form 4 sale | 1,864 | $119k | 1.6% | Plan not stated | SEC |
| Oct 2, 2017 | Oct 4, 2017 | Foundation Medicine, Inc. | SVP and General Counsel | Form 4 sale | 2,165 | $84k | 1.8% | Plan not stated | SEC |
| Jul 6, 2017 | Jul 7, 2017 | Foundation Medicine, Inc. | SVP and General Counsel | Form 4 sale | 5,070 | $197k | 4.0% | Plan not stated | SEC |
| May 12, 2017 | May 16, 2017 | Foundation Medicine, Inc. | SVP and General Counsel | Form 4 sale | 1,009 | $34k | 0.8% | Plan not stated | SEC |
| Apr 3, 2017 | Apr 5, 2017 | Foundation Medicine, Inc. | SVP and General Counsel | Form 4 sale | 1,233 | $39k | 1.2% | Plan not stated | SEC |
| Mar 16, 2017 | Mar 20, 2017 | Foundation Medicine, Inc. | SVP and General Counsel | Form 4 sale | 6,231 | $197k | 5.6% | Plan not stated | SEC |
| Jan 4, 2017 | Jan 5, 2017 | Foundation Medicine, Inc. | SVP and General Counsel | Form 4 sale | 4,682 | $83k | 4.1% | Plan not stated | SEC |
| Oct 4, 2016 | Oct 5, 2016 | Foundation Medicine, Inc. | SVP and General Counsel | Form 4 sale | 1,220 | $29k | 1.0% | Plan not stated | SEC |
| Jul 5, 2016 | Jul 6, 2016 | Foundation Medicine, Inc. | SVP and General Counsel | Form 4 sale | 4,705 | $83k | 4.2% | Plan not stated | SEC |
| Mar 5, 2015 | Mar 10, 2015 | Foundation Medicine, Inc. | SVP and General Counsel | Form 4 sale | 4,635 | $219k | 6.4% | Plan not stated | SEC |
| Mar 2, 2015 | Mar 4, 2015 | Foundation Medicine, Inc. | SVP and General Counsel | Form 4 sale | 1,424 | $69k | 1.9% | Plan not stated | SEC |
| Jan 12, 2015 | Jan 14, 2015 | Foundation Medicine, Inc. | SVP and General Counsel | Form 4 sale | 7,000 | $365k | 10.4% | Plan not stated | SEC |
| Jan 8, 2015 | Jan 12, 2015 | Foundation Medicine, Inc. | SVP and General Counsel | Form 4 sale | 4,000 | $92k | 5.6% | Plan not stated | SEC |
| Oct 17, 2014 | Oct 21, 2014 | Foundation Medicine, Inc. | SVP and General Counsel | Form 4 sale | 4,000 | $93k | 5.3% | Plan not stated | SEC |
| Jul 8, 2014 | Jul 9, 2014 | Foundation Medicine, Inc. | SVP and General Counsel | Form 4 sale | 4,000 | $109k | 5.1% | Plan not stated | SEC |